info@biomedres.us   +1 (720) 414-3554   One Westbrook Corporate Center, Suite 300, Westchester, IL 60154, USA   Site Map
ISSN: 2574 -1241

Impact Factor : 0.548

  Submit Manuscript

Case ReportOpen Access

Lenvatinib in Metastatic DTC (Differentiated Thyroid Cancer)- A Pragmatic Approach with Dosing

Arif Shaukat* and J Ansari

DOI: 10.26717/BJSTR.2017.01.000156

  • Author Information Open or Close
    • Prince Sultan Military Medical City Riyadh, Saudi Arabia

    *Corresponding author: Arif Adnan Shaukat, Prince Sultan Military Medical City Riyadh, KSA, Saudi Arabia

Received: June 18, 2017   Published: June 29, 2017

To view the Full Article   Peer-reviewed Article PDF

Abstract

Keywords: Differentiated thyroid cancer (DTC); Lenvatinib; Multi kinase inhibitors; Metastatic; Radio iodine refractory

Abbreviations:

RR-DTC: Radio iodine refractory Differentiated Thyroid Cancers

Introduction | Case 1 | Case 2 | Case 3 | Discussion | Conclusion | References |